Cadian Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100,000	Closed	-$12.4M	–	34
2018 Q4	$12.4M	Buy	+100,000	New	+$14.8M	0.58%	25
2018 Q3	–	Sell	-725,092	Closed	-$125M	–	30
2018 Q2	$125M	Sell	725,092 -486,497	-40%	-$79.5M	6.01%	6
2018 Q1	$183M	Sell	1,211,589 -73,600	-6%	-$10.8M	9.88%	2
2017 Q4	$173M	Buy	1,285,189 +106,241	+9%	+$14.7M	10.61%	3
2017 Q3	$172M	Sell	1,178,948 -213,627	-15%	-$32.3M	8.1%	4
2017 Q2	$217M	Buy	1,392,575 +173,812	+14%	+$26.6M	10.55%	1
2017 Q1	$177M	Sell	1,218,763 -322,019	-21%	-$41.9M	8.46%	1
2016 Q4	$168M	Buy	1,540,782 +229,490	+18%	+$25.6M	8.98%	1
2016 Q3	$159M	Buy	1,311,292 +547,056	+72%	+$73.7M	8.45%	2
2016 Q2	$108M	Buy	764,236 +290,000	+61%	+$42.8M	6.05%	6
2016 Q1	$61.9M	Sell	474,236 -54,580	-10%	-$6.79M	4.24%	7
2015 Q4	$74.3M	Buy	528,816 +200,141	+61%	+$27.7M	2.79%	13
2015 Q3	$43.7M	Buy	328,675 +153,675	+88%	+$26.5M	1.74%	18
2015 Q2	$30.8M	Buy	175,000 +65,000	+59%	+$11.7M	0.96%	29
2015 Q1	$19M	Buy	+110,000	New	+$18.9M	0.55%	40